Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
276M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
60.4M
-
Shares change
-
+1.28M
-
Total reported value, excl. options
-
$198M
-
Value change
-
+$1.33M
-
Put/Call ratio
-
0.54
-
Number of buys
-
32
-
Number of sells
-
-37
-
Price
-
$3.28
Significant Holders of Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD) as of Q2 2022
90 filings reported holding IVVD - Invivyd, Inc. - Common Stock, $0.0001 par value per share as of Q2 2022.
Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.4M shares
of 276M outstanding shares and own 21.9% of the company stock.
Largest 10 shareholders include FMR LLC (15.2M shares), M28 Capital Management LP (6.4M shares), Alphabet Inc. (5.68M shares), ORBIMED ADVISORS LLC (5.06M shares), Slate Path Capital LP (3.74M shares), 683 Capital Management, LLC (3.6M shares), VANGUARD GROUP INC (3.3M shares), BlackRock Inc. (3.1M shares), Bain Capital Life Sciences Investors, LLC (1.94M shares), and Redmile Group, LLC (1.92M shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.